Now, the Chicago pharma has done just that by striking a deal with a slate of generics manufacturers that waylays the entry ...

AbbVie (NYSE:ABBV) announced on Thursday that the company has reached settlements with all generic drugmakers to resolve ...

The news that the brand is protected from generics for more than a decade "gives AbbVie a kind of tremendous runway," to sell ...

Penn researchers say they will pursue larger-scale studies to continue testing whether hydroxychloroquine and everolimus can ...

The biopharmaceutical company doesn’t expect U.S. generic entry for the drug before 2037 now that it has settled litigation.

Rapamycin is an immune suppressant often used in organ transplant patients, but it has also been shown to extend life in ...

Biocon CEO Siddharth Mittal reveals plans to launch generic versions of diabetes drug Ozempic in key markets by the end of ...

Generic drugs account for more than 90 percent of prescriptions filled in the United States. Recent studies have found concering variability in quality and safety America’s generic drug supply, most ...

Zentiva's operations span the development, production and distribution of medicines in more than 30 countries.

Virginia has outpaced the national average in Medicaid spending, an analysis of data by groups of pharmacists found. The ...